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Some persons argue that the routine addition of antibiotics to animal feed will help alleviate protein undernutrition in
developing countries by increasing meat production. In contrast, we estimate that, if all routine antibiotic use in animal feed
were ceased, there would be negligible effects in these countries. Poultry and pork production are unlikely to decrease by
more than 2%. Average daily protein supply would decrease by no more than 0.1 g per person (or 0.2% of total protein
intake). Eliminating the routine use of in-feed antibiotics will improve human and animal health, by reducing the development
and spread of antibiotic-resistant bacteria.
Protein and energy undernutrition in many developing coun-
tries remains an enormous problem [1, 2]. The increased pro-
duction and consumption of animal products (meats and milk)
have been seen as a solution for protein undernutrition, because
meat has much higher protein content than do vegetal (i.e.,
plant-derived) products. Many governments have adopted pol-
icies to promote “industrialized meat” production [3, 4] (i.e.,
meat from animals raised in intensive production systems using
prescribed feed intakes). Until recently, nearly all large-scale
and intensive meat production in developed countries involved
continuous administration of in-feed antibiotics because of
purported growth promotion and “disease prevention” effects
in animals fed continuous antibiotics. This practice was largely
accepted unquestioningly in developing countries, despite the
long-standing controversy surrounding it in developed coun-
tries [5–8]. Critics of the routine use of antibiotic additives in
industrialized meat production have pointed mainly to the risk
of spread of antibiotic-resistant bacteria to people via the food
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chain and wastewater [5, 7, 8]. In opposition to this position,
others have argued that continuous use of in-feed antibiotics
is essential for the economic viability of industrialized meat
production and that, in turn, industrialized meat production
is necessary to solve protein undernutrition in developing coun-
tries. There have even been suggestions that starvation would
result without this antibiotic use [9, 10].
This article examines the evidence for claims that routine
in-feed use of antibiotics increases the production of meat for
human consumption in developing countries. We have done
this by estimating the potential loss of protein production likely
to occur if the in-feed use of antibiotics for growth promotion
in industrialized meat production was eliminated. We also dis-
cuss some of the hazards of routine antibiotic use. Finally, we
examine whether increased industrialized meat production can
successfully solve protein undernutrition.
THE USE OF LARGE QUANTITIES OF
ANTIBIOTICS AS GROWTH PROMOTERS IN
ANIMALS IS A PUBLIC HEALTH HAZARD
The prolonged used of antibiotics, whether in humans or an-
imals, creates evolutionary pressure for the development of
antibiotic resistance [11]. In general, this pressure is propor-
tional to the quantity of antibiotics used, although the class of
antibiotic and the ways in which they are used are also im-
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Figure 1. Meat production per year in developing countries (from [18])
portant. The limited data available show that very large
amounts of antibiotics are used in agriculture in nearly every
country, mostly as feed additives to promote animal growth in
intensive, industrial (“landless”) farms. In Australia (1992–
1997), Denmark (1995) and the United States (late 1990s),
more than two-thirds of all antibiotic use involved food animals
[7, 12–14]. However, in some developed countries, the situation
is changing. In 1999, the European Union banned the use of
many antibiotics for growth-promotion purposes, and use of
the remaining agents is to be phased out by 2006 [15]. The
McDonald’s Corporation [16] has recently introduced a policy
similar to that of the European Union for its meat suppliers
that is likely to have a global impact. It is in developing coun-
tries, however, where the largest increases in industrialized meat
production (especially poultry production) are occurring,
where it is harder to successfully regulate the use of antibiotics,
and where “critically important” human antibiotics (such as
fluoroquinolones) are used in large quantities for nonthera-
peutic uses in healthy animals.
Antibiotic-resistant bacteria carried by animals can enter the
human food chain through the consumption of meat or other
animal products, through farm runoff water, and by other path-
ways. Meats frequently became contaminated with antibiotic-
resistant bacteria, particularly during the process of slaughter-
ing. There are many human health problems that result from
the spread of antibiotic-resistant bacteria acquired from animals
[17]. Antibiotic exposure in animals also promotes the ampli-
fication of resistance genes that, once transmitted to humans,
can then be transmitted within humans to more pathogenic
bacteria.
Poultry, cattle, and pork are the main livestock in which
continuous in-feed antibiotics are used (for purported growth
promotion and disease prevention). Antibiotics are also used
extensively in aquaculture, but very limited data are currently
available on the extent and consequences of this practice (for
this reason, aquaculture is not further discussed in this article).
Most cattle and sheep in developing countries are raised on
grasslands and do not receive antibiotics as in-feed additives
(compared with an increasing proportion of cattle raised in
feed lots in developed countries). Therefore, this article focuses
on poultry and pork production, to evaluate the potential value
of continuous in-feed use of antibiotics in developing countries
as growth promoters. Pig and chicken meats have had the
largest increases in both meat production and consumption in
the past 50 years in developing countries (figure 1) [18].
DO ANTIBIOTICS FUNCTION AS EFFECTIVE
GROWTH PROMOTERS?
It is commonly assumed that significant weight gains in animals
result from the in-feed use of antibiotics, especially in devel-
oping countries. However, it remains unclear how much of an
increase, if any, in meat production results from routine use
of in-feed additives in industrialized meat production. There
are no double-blind, placebo-controlled studies of the contin-
uous use of in-feed antibiotics for growth promotion. The lim-
ited comparative studies of in-feed antibiotic use from devel-
oped countries that are available have shown remarkably few
benefits [19–21]. Even data supplied by pharmaceutical com-
panies for their own products show very modest weight gain
benefits (∼2% or less for virginiamycin) [12, 22]. Consistent
with this general impression of modest effect, the data presented
by pharmaceutical companies for their competitors’ products
show even poorer performance for weight gain, compared with
control animals (e.g., 0.4% for avoparcin) [22].
Danish poultry growers voluntarily ceased all routine in-feed
antibiotic use in February 1998 in response to concern over
the risk to public health. Chicken production has not suffered
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economically as a result. Meat production and chicken weights
have been maintained, as has the output of chicken meat per
square meter of pen size [21, 23]. In this nationwide interven-
tion in Denmark, the only economic parameter that decreased
after cessation of antibiotic use was that feed intake increased,
as indicated by a 1% increase in Feed Conversion Efficiency
(FCE). However, the savings from not purchasing antibiotic
additives substantially offset this small increase in feed cost.
Furthermore, routine in-feed antibiotic use does not decrease
mortality among food animals in developed countries. In stud-
ies reported by Pfizer, neither virginiamycin use nor avoparcin
use reduced mortality among meat chickens (the mortality rate
was 3.9% for control animals and 4.8% for broilers that received
virginiamycin) [12]. In Denmark, no increase in mortality was
observed after the cessation of in-feed antibiotic use in poultry
[21, 23]. Similarly, in a study involving close to 7 million chick-
ens in the United States, no statistically significant effects were
seen on mortality (or weight gain) after the routine use of in-
feed antibiotics in poultry was stopped [19].
Data from developing countries are far more limited. Because
animals may be under greater stress (for such reasons as poorer
food quality or greater ambient temperature), it is often as-
sumed that benefits will be commensurately larger. However,
the limited data available question this assumption. Unpub-
lished studies by poultry producers in Brazil that involved 15
million chickens were submitted in response to a “call for data”
before the World Health Organization (WHO) meeting on an-
tibiotic use in food animals in Oslo, Norway, in 2001 [24].
These data showed that the weight gains associated with an-
tibiotic use are variable, and the change in weight is, at most,
only ∼2%. One small study from India attributed a 9% weight
gain to antibiotic use [25]. However, in this study, the final
weight of the chickens after 6 weeks of antibiotic use (1141 g)
was only approximately one-half of the weight of chickens
reared without continuous antibiotic administration in devel-
oped countries (e.g., Denmark) or in Brazil.
THE GLOBAL PRODUCTION AND
DISTRIBUTION OF CALORIES
AND PROTEIN
In the developing world, calorie and protein consumption has
increased markedly in the past 30 years. In most countries,
foods available for consumption now exceed the recommended
minimum daily intake for an individual [3, 4]. However, despite
this seeming abundance, protein-energy undernutrition re-
mains seemingly intractable in many developing countries, es-
pecially in sub-Saharan Africa and parts of South Asia [1, 2].
It has long been noted by writers who comment about fam-
ine, hunger, and undernutrition that food insecurity is more
likely to be caused by the maldistribution of food and food
“entitlement” (e.g., income) than deficiencies in the total food
supply [26]. Globally, the present is a time of ample total food
supply, yet the distribution of consumption of different kinds
of food remains markedly unequal and appears to be becoming
more unequal [27–29]. Urban populations are consistently
more affluent and better fed than are rural populations.
The maldistribution of the food that is grown and produced
harms the overnourished as well as those who remain un-
dernourished. Obesity, well recognized to increase the risk of
diabetes, cardiovascular disease, and some forms of cancer, is
increasing in many developing countries and may even lead
to a decline in life expectancy in some developed countries
[3, 4, 29].
There is increasing recognition that excessive quantities of
animal-derived foods may be suboptimal for a healthy diet.
These concerns also relate to the composition of saturated
fats and dietary cholesterol, abundant in many fatty products
of animal origin. Indeed, the WHO has cautioned authorities
in developing countries against the blind imitation of agri-
cultural and farming techniques from developed countries
that are based on nutritional knowledge that is becoming
outmoded [3, 4].
THE POOR RARELY—IF EVER—EAT MEAT
PRODUCED WITH CONTINUOUS IN-FEED
ANTIBIOTICS
The majority of the world’s poor live in rural areas. These areas
are usually characterized by poor infrastructure, limited food
distribution networks, and minimal means of refrigeration. To-
gether, these factors restrict the distribution and sale of indus-
trialized meats. More importantly, the poor generally lack the
financial means (the “entitlement”) [26] to purchase meat, even
if it were available or culturally permitted (e.g., to vegetarians).
The poor prefer cereals as the staple energy source because of
its far lower cost per calorie (it is ∼15% less expensive, com-
pared with the cost per calorie for meat). On a population level,
significant quantities of meat are not consumed until the ma-
jority of people have already passed a minimum intake of pro-
tein and calories through the consumption of cereal and other
vegetal products. Most of the limited quantity of chicken and
pork that the poor do consume in rural areas are grown locally
with animals that rely on scavenging and thus would not receive
routine in-feed antibiotics.
Most industrialized meats consumed in developing countries
are sold and eaten in or near cities and are increasingly con-
sumed by a population whose major nutritional problem is
obesity. Therefore, even if the continuous in-feed use of anti-
biotics in these countries were discontinued and were to cause
an (unlikely) fall in production of 10%, undernutrition in any
segment of the population is unlikely to result.
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calories Fat, g Protein, g
Butter/ghee 19.3 2.2 0
Whole milk 58.3 3.4 2.9
Bovine meat 29.5 2.1 2.5
Fish/seafood 23.2 0.7 3.8
Freshwater fish 9.8 0.4 1.5
Pig meat 109.4 10.5 3.5
Poultry meat 33.1 2.4 2.6
Poultry and pig meat combined 142.5 12.9 6.1
All meats 184.1 15.8 9.6
Vegetal products 2307.6 47.4 38
10% of poultry and pig meat produced 14.3 1.3 0.6
Totala 2666 65.2 68.5
Total if 10% of pork and poultry is removeda 2651.70 63.9 67.9
NOTE. From [18].
a Total is for all dietary sources of protein, including minor sources that are not listed.
THE USE OF IN-FEED ANTIBIOTICS MAY HARM
THE POOR IN DEVELOPING COUNTRIES
The increase in the total production of meat may harm the
poor in other ways. The economies of scale permitted by large-
scale industrial meat production (often in tandem with gov-
ernment subsidies, many of which may be hidden) leads to
market distortion. Roads and other subsidized infrastructure
can sometimes allow the long-distance transportation of ani-
mals produced by the industrialized sector to central markets.
Thus, as supply increases, prices will usually fall. These lower
prices allow increased meat consumption by many middle-class
consumers, yet they depress the price received for animals
grown for sale by the poor.
HIGHER PRICES FOR CEREALS
In recent years, the worldwide production of cereals (and soy)
has decreased on a per capita basis [27]. At the same time,
increasing amounts of these crops are being used as animal
feed. The available “supply” of grain and soy for human con-
sumption is thus likely to be relatively smaller, and this is a
plausible cofactor for the increased maldistribution of energy
intake observed since 1990 [28]. These competing demands
will also have an influence on price.
LITTLE EXTRA EMPLOYMENT
Increased employment in the industrialized meat sector is un-
likely to significantly reduce poverty levels. Although some in-
dividuals will find jobs in this sector, overall rates of employ-
ment in the farm sector are decreasing (including in many
developing countries) as that sector becomes increasingly cap-
ital and energy intensive [27].
THE CONTRIBUTION OF INDUSTRIALIZED
MEATS TO IMPROVED NUTRITION IN
DEVELOPING COUNTIES IS NEGLIGIBLE
Poultry and pork are the main industrialized meats produced
in developing countries. We used Food and Agriculture Or-
ganization of the United Nations statistical databases data to
evaluate the contribution of each of these meats to national
nutrition (table 1) [18]. These data have been used to model
the effect of removing antibiotics as growth promoters in de-
veloping countries. We have assumed (optimistically) that 10%
of all poultry and pork produced can be attributed to the
growth promotion effects of antibiotics in animal feed, con-
sistent with the highest figure claimed by proponents of this
practice. However, other evidence we have presented suggests
that 2% is a more realistic estimate; this latter figure has also
been modelled.
Because most protein available in developing countries is
of vegetal origin, a decrease in the fraction of the industri-
alized production of pork and poultry by 10% represents only
a trivial decline of 0.6 g/day in total daily protein supply (table
1). This represents a mere 0.9% reduction in the average
available total daily protein intake of 68.5 g/day. Fat intake
would also fall but by a larger amount (1.3 g/day, or 2%).
Furthermore, there is no developing country where even a
loss as high as 10% in industrialized meat production shifts
the protein intake to less than levels that are deleterious to a
population’s nutrition (table 2). The largest effects were seen
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Table 2. Changes in availability of dietary protein in selected developing countries if continuous in-feed antibiotics were not used
in pork and poultry production, 2002
Region
Protein intake by source, g/day
Change with 2% less pig
and poultry production
Total protein intake






if 2% of pig
and poultry intake










Angola 44.8 2.2 1 0.1 44.7 44.5 0.1
Chad 64.7 0.2 0 0 64.7 64.7 0.0
Congo 24.7 0.2 0.2 0 24.7 24.7 0.0
Egypt 95.4 3.2 0 0.1 95.3 95.1 0.1
Eritrea 45.3 0.2 0 0 45.3 45.3 0.0
Liberia 30.8 1.1 0.5 0 30.8 30.6 0.1
Mozambique 39.5 0.9 0.2 0 39.5 39.4 0.1
Rwanda 48.5 0.1 0.1 0 48.4 48.5 0.1
Zimbabwe 42.9 0.9 0.6 0 42.9 42.8 0.1
Americas
Argentina 96 8 1.8 0.2 95.8 95 0.2
Bolivia 59.3 5 3 0.2 59.1 58.5 0.3
Brazil 82.8 10 3.4 0.3 82.5 81.5 0.3
Haiti 46.1 1.2 1.3 0.1 46.1 45.9 0.1
Mexico 90.8 7.1 3.8 0.2 90.6 89.7 0.2
Asia/Pacific
Bangladesh 48.1 0.3 0 0 48.1 48.1 0.0
Barbados 94 15.8 4.1 0.4 93.6 92 0.4
China 81.5 3.4 10.4 0.3 81.2 80.1 0.3
India 57.3 0.4 0.2 0 57.3 57.2 0.0
Indonesia 64.2 1.3 0.7 0 64.2 64.1 0.1
The Philippines 56.1 2.8 5.3 0.2 55.9 55.3 0.3
Solomon Islands 51 0.4 1.5 0 51 50.8 0.0
Thailand 57 4.9 2.5 0.1 56.9 56.4 0.2
Vietnam 62.3 1.7 6.2 0.2 62.3 62.1 0.1
NOTE. From [18].
a From all protein sources.
in countries with high average daily protein and fat intakes
(e.g., China and Argentina) and where obesity is a major
problem [3, 4]. In countries with relatively low per capita
protein intakes (50–60 g/day), the protein supply remains at
150 g/day in all countries where this was the case prior to
our modelling exercise. Pork and poultry intakes are usually
very small in countries with very low (!50 g/day) per capita
protein availability. In these countries, a decrease of 10% in
the supply of pork and poultry makes almost no change to
the population’s average daily protein intake (table 2).
In reality, the weight gain in animals fed antibiotics is likely
to be much less than 10%, and not all animals will receive in-
feed antibiotics (e.g., animals on small family farms). If we
assume that antibiotic use increases weight by 2%, then the
decrease in protein intake for “all developed countries” com-
bined is only 0.1 g/day, or 0.2%. Thus, the resultant loss of
protein intake in malnourished people if antibiotics were not
used routinely in poultry and pigs is likely to be extremely
small.
The use of in-feed antibiotics may paradoxically harm na-
tional nutrition. The segment of the population that currently
consumes most of this industrially produced meat (and, thus,
a high content of saturated fats) faces a greater problem with
obesity than with protein-energy undernutrition [3, 4]. De-
creasing the supply of industrialized meat by 10% should lead
to a decrease in overall consumption of meat by a similar
amount in the population. Where pork is a major component
of this industrialized meat production, a 10% decrease in meat
intake will generate a far larger decrease in fat intake rather
than in protein intake. For instance, in China, in 2002, the
average daily intake of fat from pork was 31.8 g, compared
with a protein intake of 10.4 g [18]. Therefore, every 1-g of
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protein intake from pig meat is associated with a much larger
3.1-g intake of fat.
WHO BENEFITS FROM INDUSTRIALIZED MEAT
PRODUCTION IN DEVELOPING COUNTRIES?
Manufactures and sellers of antibiotics benefit from current
practices because they derive income from selling these prod-
ucts. Consumers appear to gain because they can afford to buy
increased quantities of industrialized meats, which are often
made to be cheaper by government subsidies.
It might be anticipated that meat producers (usually large
corporations) would profit from antibiotic use because of the
increased production claimed by its proponents claim. How-
ever, a recent economic analysis performed by the US De-
partment of Agriculture [30] casts doubt on this assumption.
This report concluded that, overall, meat producers reaped
minimal or no financial benefits. It was calculated that the US
hog industry would have a net saving of $7 million if the use
of antibiotic growth promoters ceased.
CONCLUSIONS
Some proponents of the routine feeding of antibiotics to ani-
mals in industrial farms claim that animal weight increases by
as much as 10%. This has led to assertions that in-feed anti-
biotics increase meat production and protein consumption by
the poor in developing countries and that starvation will result
if this practice ceases. However, we have shown that animal
weight gains are likely no more than 2% (or would be non-
existent). Furthermore, “industrialized meat” production in de-
veloping countries offers little benefit to the vast majority of
the poor, who for entrenched structural reasons lack access and
“entitlement” to these meats. Those who do consume these
industrialized meats are more affluent and are, paradoxically,
experiencing substantial rates of obesity.
We are not arguing that meat should not be consumed in
developing countries or that it should not be produced as ef-
ficiently as possible. Meat is a valuable contributor to nutrition,
although it can be harmful if eaten in excess. However, any
loss of production of industrialized meat because of the with-
drawal of in-feed antibiotic use is unlikely to have any adverse
nutritional effect, including for the poor. Instead, the public
health effects are likely to be strongly beneficial, particularly by
protecting the public good of reduced bacterial resistance to
antibiotics.
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